- Barings will continue to manage the hotel assets for new owner
- Portfolio consists of seven upper-upscale business class hotels in five major U.S. markets
CHARLOTTE, N.C., Feb. 05, 2018 -- Barings, one of the world’s leading asset management firms, announced on behalf of its client, a major international financial services company, the $650 million sale of seven U.S. hotels to a Hong Kong-based investment management company. Barings is being retained by the new owner as asset manager for the hotel portfolio on a long-term basis, and all hotel operation will continue as usual with no change in current hotel management companies or personnel.
Barings’ expertise as a global leader in real estate investment management enabled it to conduct the search for new investors, directly arrange the sale between its client and the new buyer without a broker, and play a significant role in securing private financing for the portfolio with three separate lenders.
“This transaction reflects the value Barings is able to provide to clients through our depth, global reach and our ability to source and manage real estate investment opportunities and serve clients’ capital needs worldwide,” said Scott Brown, Global Head of Real Estate at Barings. “We are delighted to welcome a significant, sophisticated and experienced client to the Barings Real Estate platform and will utilize our deep knowledge in managing hospitality investments to maximize the potential of this group of quality assets for our new partner.”
The portfolio comprises seven upper-upscale business class hotels in the Chicago, Boston, Washington, Seattle and Phoenix metropolitan areas.
“As an asset class, commercial real estate equity continues to attract investors seeking risk-adjusted returns, and assuming an adequate hold period, well-located quality hotel properties also represent a good portfolio diversifier,” said Michael Zammitti, Head of U.S. Real Estate Equity at Barings. Jim O’Shaughnessy, a managing director at Barings Real Estate shared, “We are grateful for the opportunity to apply the deep expertise of our hotel investment and asset management team, our research-focused investment process and rigorous financial reporting to leverage the significant value of this portfolio on behalf of our new client.”
About Barings
Barings is a $304+ billion* global financial services firm dedicated to meeting the evolving investment and capital needs of our clients. We build lasting partnerships that leverage our distinctive expertise across traditional and alternative asset classes to deliver innovative solutions and exceptional service. Part of MassMutual, Barings maintains a strong global presence with over 1,800 professionals and offices in 16 countries. Learn more at www.barings.com.
*As of December 31, 2017
18/417628
Contact: Brian Whelan, Barings, 704.805.7244, [email protected]


Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 



